+
Divi’s Labs Signs Long-Term Supply Deal with Global Pharma Company
ECONOMY & POLICY

Divi’s Labs Signs Long-Term Supply Deal with Global Pharma Company

Divi’s Laboratories Ltd has entered into a long-term supply agreement with a global pharmaceutical company for the manufacture and delivery of advanced intermediates, the company said in a regulatory filing on Friday.

Though the identity of the global partner was not disclosed, Divi’s stated that it expects meaningful revenue contribution from the arrangement. To support this agreement and future growth, the company plans to invest between Rs 6.5 billion and Rs seven billion in capacity addition at its manufacturing facilities. The expansion will be funded entirely through internal accruals.

This move is seen as a strategic step towards strengthening Divi’s position in the global pharmaceutical supply chain and scaling up production capabilities. The firm, known for supplying active pharmaceutical ingredients and intermediates, has previously maintained long-standing partnerships with several multinational drug makers.

Shares of Divi’s Laboratories closed 2.07 per cent lower at Rs 5,638.35 apiece on the Bombay Stock Exchange.

Source: Press Trust of India

Divi’s Laboratories Ltd has entered into a long-term supply agreement with a global pharmaceutical company for the manufacture and delivery of advanced intermediates, the company said in a regulatory filing on Friday. Though the identity of the global partner was not disclosed, Divi’s stated that it expects meaningful revenue contribution from the arrangement. To support this agreement and future growth, the company plans to invest between Rs 6.5 billion and Rs seven billion in capacity addition at its manufacturing facilities. The expansion will be funded entirely through internal accruals. This move is seen as a strategic step towards strengthening Divi’s position in the global pharmaceutical supply chain and scaling up production capabilities. The firm, known for supplying active pharmaceutical ingredients and intermediates, has previously maintained long-standing partnerships with several multinational drug makers. Shares of Divi’s Laboratories closed 2.07 per cent lower at Rs 5,638.35 apiece on the Bombay Stock Exchange. Source: Press Trust of India

Next Story
Real Estate

We aim to grow strategically across the redevelopment and mid-premium segments

With over 10 million sq ft delivered and more than 10,000 families served, Ramky Estates has emerged as a trusted name in responsible urban development. In this conversation with CW, Nanda Kishore, Managing Director, Ramky Estates, shares insights on the company’s growth philosophy, foray into the Mumbai market, commitment to sustainability, and vision for future-ready communities that blend smart living with long-term value creation.Over 10 million sq ft delivered is no small feat – what has been the driving ethos behind Ramky Estates’ journey so far?Real estate is not just a secto..

Next Story
Real Estate

We aim to triple our India business by 2030

Step into a TOTO bathroom and you don’t just see design – you feel it. From the soft, warm seat to the gentle rhythm of cleansing water and silent air drying, every interaction is engineered for delight. TOTO doesn’t sell products; it crafts rituals. With Japan’s legacy of innovation and India’s appetite for refined living, the brand is not just redefining luxury – it’s awakening the senses, one ‘Washlet’ at a time.In an exclusive conversation with FALGUNI PADODE, Group Managing Editor, CW, Shiozawa Kazuyuki, Managing Director, and Kokubu Yohei, Sales Unit Head, TOTO Ind..

Next Story
Real Estate

Not Just Glass Boxes!

India is moving away from the ‘glass box’ syndrome, all-glass façades that were widely used in commercial buildings in the last two decades but came at a significant environmental cost given the country’s predominantly hot and humid climate. Poor thermal performance, excessive heat gain and dependency on mechanical cooling systems made buildings with glass façades energy guzzlers and significantly increased their carbon footprint.That said, it’s important to be aware that “glass is not the enemy,” points out Heena Bhargava, Architect, Architecture Discipline. “How it is used ma..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?